Ambulatory high-dose 5-day continuous-infusion ifosfamide combination chemotherapy in advanced solid tumors: a feasibility study T. M. LoefflerF. W. WeberT. U. Hausamen OriginalPaper Pages: S125 - S128
Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility T. CernyA. GrafA. Küpfer OriginalPaper Pages: S129 - S134
Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II study T. CernyG. MartinelliA. Küpfer OriginalPaper Pages: S135 - S138
A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer H. AndersonJ. PrendivilleR. Swindell OriginalPaper Pages: S139 - S140
Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients Rolf D. IsselsJohann MittermüllerWolfgang Wilmanns OriginalPaper Pages: S141 - S147
Metabolism and pharmacokinetics of oral and intravenous ifosfamide V. KurowskiT. CernyT. Wagner OriginalPaper Pages: S148 - S153
The stability of ifosfamide in aqueous solution and its suitability for continuous 7-day infusion by ambulatory pump J. A. RadfordJ. M. MargisonN. Thatcher OriginalPaper Pages: S154 - S156
In vitro studies on drug interaction of ifosfamide and ACNU in primary and metastatic human brain tumours Ulrich BogdahnDaniela DrenkardChristian Behl OriginalPaper Pages: S157 - S163
Dosing and side-effects of ifosfamide plus mesna W. P. BradeK. HerdrichC. E. Araujo OriginalPaper Pages: S164 - S186
Combined chemo- and radiosensitivity testing with ifosfamide and ACNU in human lung cancer cell lines M. WolfM. MaasbergK. Havemann OriginalPaper Pages: S187 - S192
Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma Group W. P. StewardJ. VerweijK. Kelly OriginalPaper Pages: S193 - S197
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinoma A. HarstrickH. -J. SchmollH. Poliwoda OriginalPaper Pages: S198 - S202
Effect of rhGM-CSF on haematopoietic reconstitution after chemotherapy in small-cell lung cancer K. HavemannM. KlausmannW. Oster OriginalPaper Pages: S203 - S207
Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study Anthony D. EliasLois J. AyashKaren H. Antman OriginalPaper Pages: S208 - S213
Combination of interferons and cytostatic drugs for treatment of advanced colorectal cancer H. O. KleinG. GolbachC. Bernhardt OriginalPaper Pages: S214 - S220
Ifosfamide, vindesine and recombinant α-interferon combination chemotherapy for metastatic renal cell carcinoma H. J. KönigW. GutmannJ. Weissmüller OriginalPaper Pages: S221 - S223
Ifosfamide and ACNU in experimental allogeneic bone marrow transplantation W. GassmannA. ErbersdoblerW. Mueller-Ruchholtz OriginalPaper Pages: S224 - S227